(Q30372278)

21 June 2017

1 reference

title

HIV immunopathogenesis and strategies for intervention. (English)

1 reference

21 June 2017

1 reference

Martin Cadogan

1

1 reference

21 June 2017

Angus G Dalgleish

series ordinal

2

1 reference

21 June 2017

publication date

23 September 2008

1 reference

Lancet Infectious Diseases

21 June 2017

published in

1 reference

21 June 2017

volume

8

1 reference

21 June 2017

issue

11

1 reference

21 June 2017

page(s)

675-684

1 reference

CD4+ T-cell depletion in HIV infection: Are we closer to understanding the cause?

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Persistent immune activation in HIV-1 infection is associated with progression to AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

In vivo analysis of Fas/FasL interactions in HIV-infected patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Dynamic correlation of apoptosis and immune activation during treatment of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4+ and CD8+ T cell turnover in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

T Cell Activation Is Associated with Lower CD4+T Cell Gains in Human Immunodeficiency Virus–Infected Patients with Sustained Viral Suppression during Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Paradoxical CD4+ T-cell decline in HIV-infected patients with complete virus suppression taking tenofovir and didanosine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Low CD4+ T-cell counts in HIV patients receiving effective antiretroviral therapy are associated with CD4+ T-cell activation and senescence but not with lower effector memory T-cell function.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

CD4+ T-Cell Immunodeficiency Is More Dependent on Immune Activation Than Viral Load in HIV-Infected Children on Highly Active Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Evidence for rapid disappearance of initially expanded HIV-specific CD8+ T cell clones during primary HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Rapid evolution of the neutralizing antibody response to HIV type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Antibody neutralization and escape by HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Development of the antibody response in acute HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Therapeutic AIDS vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Partial activation and induction of apoptosis in CD4(+) and CD8(+) T lymphocytes by conformationally authentic noninfectious human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Diminished spontaneous apoptosis in lymphocytes from human immunodeficiency virus-infected long-term nonprogressors

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Gut mucosal T cell responses and gene expression correlate with protection against disease in long-term HIV-1-infected nonprogressors

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Low immune activation despite high levels of pathogenic human immunodeficiency virus type 1 results in long-term asymptomatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Divergent patterns of progression to AIDS after infection from the same source: human immunodeficiency virus type 1 evolution and antiviral responses

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Pathogenesis of HIV: non-specific immune hyperactivity and its implications for vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

V3 variation in HIV-seropositive patients receiving a V3- targeted vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Down-modulation of mature major histocompatibility complex class II and up-regulation of invariant chain cell surface expression are well-conserved functions of human and simian immunodeficiency virus nef alleles.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Persistence of Extraordinarily Low Levels of Genetically Homogeneous Human Immunodeficiency Virus Type 1 in Exposed Seronegative Individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

The role of cell-to-cell transmission in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

HIV preferentially infects HIV-specific CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Preferential apoptosis of HIV-1-specific CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Complement control proteins, CD46, CD55, and CD59, as common surface constituents of human and simian immunodeficiency viruses and possible targets for vaccine protection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Human immunodeficiency virus type 1 incorporates both glycosyl phosphatidylinositol-anchored CD55 and CD59 and integral membrane CD46 at levels that protect from complement-mediated destruction

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Enhanced HIV infectivity and changes in GP120 conformation associated with viral incorporation of human leucocyte antigen class I molecules

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Virion-bound ICAM-1 and activated LFA-1: a combination of factors conferring resistance to neutralization by sera from human immunodeficiency virus type 1-infected individuals independently of the disease status and phase

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Susceptibility of HIV type 1 to the fusion inhibitor T-20 is reduced on insertion of host intercellular adhesion molecule 1 in the virus membrane

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

CD8+ T cells specific for EBV, cytomegalovirus, and influenza virus are activated during primary HIV infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Immune activation and CD8+ T-cell differentiation towards senescence in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Bystander T cell activation--implications for HIV infection and other diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Immune activation and inflammation in HIV-1 infection: causes and consequences

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Early and persistent human immunodeficiency virus type 1 (HIV-1)-specific T helper dysfunction in blood and lymph nodes following acute HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Apoptosis as an HIV strategy to escape immune attack

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

T cell activation and disease severity in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Prognostic significance of plasma markers of immune activation, HIV viral load and CD4 T-cell measurements

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Increased immune activation precedes the inflection point of CD4 T cells and the increased serum virus load in human immunodeficiency virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Wide range of viral load in healthy african green monkeys naturally infected with simian immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Correlates of preserved CD4(+) T cell homeostasis during natural, nonpathogenic simian immunodeficiency virus infection of sooty mangabeys: implications for AIDS pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

The AIDS resistance of naturally SIV-infected sooty mangabeys is independent of cellular immunity to the virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Reduced immune activation and T cell apoptosis in human immunodeficiency virus type 2 compared with type 1: correlation of T cell apoptosis with beta2 microglobulin concentration and disease evolution

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

HIV type 2 primary isolates induce a lower degree of apoptosis "in vitro" compared with HIV type 1 primary isolates

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

HIV infection of primary human T cells is determined by tunable thresholds of T cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Preferential replication of HIV-1 in the CD45RO memory cell subset of primary CD4 lymphocytes in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Preferential attachment of HIV particles to activated and CD45RO+CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Lethal T cell immunodeficiency induced by chronic costimulation via CD27-CD70 interactions

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

The gastrointestinal tract is critical to the pathogenesis of acute HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

HIV pathogenesis: the first cut is the deepest.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

HIV disease: fallout from a mucosal catastrophe?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Pathogenic effects of human herpesvirus 6 in human lymphoid tissue ex vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Measles virus induces apoptosis in uninfected bystander T cells and leads to granzyme B and caspase activation in peripheral blood mononuclear cell cultures

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Severe depletion of mucosal CD4+ T cells in AIDS-free simian immunodeficiency virus-infected sooty mangabeys

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Acute loss of intestinal CD4+ T cells is not predictive of simian immunodeficiency virus virulence

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Virally induced CD4+ T cell depletion is not sufficient to induce AIDS in a natural host

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Microbial translocation is a cause of systemic immune activation in chronic HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Viral suppression and immune restoration in the gastrointestinal mucosa of human immunodeficiency virus type 1-infected patients initiating therapy during primary or chronic infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

HIV-1 immunopathogenesis: how good interferon turns bad.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Depletion of regulatory T cells in HIV infection is associated with immune activation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Premature induction of an immunosuppressive regulatory T cell response during acute simian immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

CD25+ regulatory T cells isolated from HIV-infected individuals suppress the cytolytic and nonlytic antiviral activity of HIV-specific CD8+ T cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Suppression of HIV-specific T cell activity by lymph node CD25+ regulatory T cells from HIV-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

The dominant source of CD4+ and CD8+ T-cell activation in HIV infection is antigenic stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Pathogenesis of HIV infection: what the virus spares is as important as what it destroys

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Nef triggers a transcriptional program in T cells imitating single-signal T cell activation and inducing HIV virulence mediators

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Soluble HIV-1 gp120 enhances HIV-1 replication in non-dividing CD4+ T cells, mediated via cell signaling and Tat cofactor overexpression

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Nef-Mediated Suppression of T Cell Activation Was Lost in a Lentiviral Lineage that Gave Rise to HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

R5 and X4 HIV envelopes induce distinct gene expression profiles in primary peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

HIV glycoprotein as a superantigen. A mechanism of autoimmunity and implications for a vaccination strategy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Superantigen implicated in dependence of HIV-1 replication in T cells on TCR V beta expression

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Random depletion of T cells that bear specific T cell receptor V beta sequences in AIDS patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Low CD4 counts rather than superantigenic-like effects account for differences in expressed T-cell receptor (TCR) repertoires between HIV-1 seropositive long-term non-progressors and individuals with progressive disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Cell surface receptors, virus entry and tropism of primate lentiviruses

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Inhibition of human immunodeficiency virus type 1 Env-mediated fusion by DC-SIGN.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Isolation of primary HIV-1 that target CD8+ T lymphocytes using CD8 as a receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Molecular mimicry between HIV-1 and antigen receptor molecules: a clue to the pathogenesis of AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Autoreactivity in HIV-1 infection: the role of molecular mimicry

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

HIV. Escape artist par excellence

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Alternative conformations of HIV-1 V3 loops mimic beta hairpins in chemokines, suggesting a mechanism for coreceptor selectivity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

HIV-1 envelope protein binds to and signals through integrin α4β7, the gut mucosal homing receptor for peripheral T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

The role of host immune responses in determining the outcome of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

HLA and in vitro susceptibility to HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Considering genetic profiles in functional studies of immune responsiveness to HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Advantage of rare HLA supertype in HIV disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

A whole-genome association study of major determinants for host control of HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Identification of homologous regions in human immunodeficiency virus I gp41 and human MHC class II beta 1 domain. I. Monoclonal antibodies against the gp41-derived peptide and patients' sera react with native HLA class II antigens, suggesting a role

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

HIV and HLA similarity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

The envelope glycoprotein of HIV-1 may have incorporated the CD4 binding site from HLA-DQ beta 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Common epitope in human immunodeficiency virus (HIV) I-GP41 and HLA class II elicits immunosuppressive autoantibodies capable of contributing to immune dysfunction in HIV I-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Human immunodeficiency virus type 1 gp120 mimics a hidden monomorphic epitope borne by class I major histocompatibility complex heavy chains

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

A proposed molecular model for the carboxy terminus of HIV-1 gp120 showing structural features consistent with the presence of a T-cell alloepitope

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Human immunodeficiency virus type 1 gp120 C5 region mimics the HLA class I alpha 1 peptide-binding domain.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Identification of CD4 and major histocompatibility complex functional peptide sites and their homology with oligopeptides from human immunodeficiency virus type 1 glycoprotein gp120: role in AIDS pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

How HIV-1 lentivirus causes immune deficiency disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Exclusion of HIV epitopes shared with human proteins is prerequisite for designing safer AIDS vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Antigenic complementarity between HIV and other AIDS-associated infections results in idiotype-antiidiotype antibody complexes that cross react with lymphocyte proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Allogeneic leukocytes as a possible factor in induction of aids in homosexual men

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Altered immunoregulation and autoimmune aspects of HIV infection: relevant murine models

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

An idiotypic network model of AIDS immunopathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Does the HIV envelope induce a chronic graft-versus-host-like disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Will killing the last HIV1 particle cure AIDS patients? Doesn't CMV activation and/or a graft-versus-host component of the disease, also have to be considered? I. First of two parts

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Re-assessing the virological approach to HIV pathogenesis: can it explain AIDS as an immunological disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

HIV envelope protein is recognized as an alloantigen by human DR-specific alloreactive T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

A gp120 HIV peptide with high similarity to HLA class II beta chains enhances PPD-specific and autoreactive T cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Alloactivated cytotoxic T cells recognize the carboxy-terminal domain of human immunodeficiency virus-1 gp120 envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

HIV type 1 envelope glycoprotein 120 carboxy-terminal peptide-induced human T cell lines selectively suppress heterogeneous proliferative T cell responses to soluble antigens

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Human antibodies to immunodominant C5 region of HIV-1 gp120 cross-react with HLA class I on activated cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Distinctive features of the alpha 1-domain alpha helix of HLA-C heavy chains free of beta 2-microglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

HIV gp120 plus specific peptides are recognized in a similar manner to specific HLA plus peptide by HLA-restricted antigen-specific T-cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Mapping of allospecific T-cell recognition sites encoded by the HLA-DR4 beta 1-chain

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

T cells sensitized to synthetic HLA-DR3 peptide give evidence of continuous presentation of denatured HLA-DR3 molecules by HLA-DP.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

HLA-DR peptide-induced alloreactive T cell lines reveal an HLA-DR sequence that can be both "dominant" and "cryptic": evidence for allele-specific processing

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

HLA Homology within the C5 Domain Promotes Peptide Binding by HIV Type 1 gp120

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Stimulation of T cells by antigenic peptide complexed with isolated chains of major histocompatibility complex class II molecules

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

T-cell recognition of a chimaeric class II/class I MHC molecule and the role of L3T4

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Human immunodeficiency virus gp120 binding C'C" ridge of CD4 domain 1 is also involved in interaction with class II major histocompatibility complex molecules

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Long-Term Human Immunodeficiency Virus Infection in Asymptomatic Homosexual and Bisexual Men with Normal CD4+ Lymphocyte Counts: Immunologic and Virologic Characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Patterns of antibody reactivity to selected human immunodeficiency virus type 1 (HIV-1) gp160 epitopes in infected individuals grouped according to CD4+ cell levels

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Correlation between humoral responses to human immunodeficiency virus type 1 envelope and disease progression in early-stage infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Longitudinal analysis of the humoral immune response to human immunodeficiency virus type 1 (HIV-1) gp160 epitopes in rapidly progressing and nonprogressing HIV-1-infected subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

The conserved carboxy terminal region of HIV-1 gp120 is recognized by seronegative HIV-exposed people

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

A conserved region at the COOH terminus of human immunodeficiency virus gp120 envelope protein contains an immunodominant epitope

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Immunizations of monkeys with synthetic peptides disclose conserved areas on gp120 of human immunodeficiency virus type 1 associated with cross-neutralizing antibodies and T-cell recognition

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

One step forward, two steps back--will there ever be an AIDS vaccine?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Gut mucosa in HIV infection: "immune milk" solution

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Intravenous immunoglobulin (IVIG) treatment for modulation of immune activation in human immunodeficiency virus type 1 infected therapy-naive individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Nonneutralizing antibodies are able to inhibit human immunodeficiency virus type 1 replication in macrophages and immature dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

1 reference

7 January 2021

A replication-competent adenovirus-human immunodeficiency virus (Ad-HIV) tat and Ad-HIV env priming/Tat and envelope protein boosting regimen elicits enhanced protective efficacy against simian/human immunodeficiency virus SHIV89.6P challenge in rhe

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

Long-term HIV-specific responses and delayed resumption of antiretroviral therapy after peptide immunization targeting dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970205-6

7 January 2021

10.1016/S1473-3099(08)70205-6

Identifiers

DOI

1 reference

21 June 2017

1 reference